Top compounds associated with response to PAGE2


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.009
mRNA SMER-3 CTRPv2 pan-cancer AAC -0.097 0.01
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.085 0.01
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC -0.081 0.01
mRNA clofarabine CTRPv2 pan-cancer AAC -0.073 0.01
mRNA barasertib CTRPv2 pan-cancer AAC -0.081 0.01
mRNA Oxaliplatin CTRPv2 pan-cancer AAC -0.082 0.01
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.01
mRNA parbendazole CTRPv2 pan-cancer AAC -0.076 0.01
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC -0.076 0.01
Download CSV